Feline Calicivirus: Treatment and Management
For cats infected with feline calicivirus (FCV), treatment is primarily supportive, focusing on intensive nursing care, fluid therapy, nutritional support, and prevention of secondary bacterial infections with broad-spectrum antibiotics. There are no FDA-approved direct-acting antivirals for FCV, though emerging evidence suggests potential benefit from specific antiviral agents in severe cases.
Core Treatment Approach
Supportive Care (Essential Foundation)
- Fluid therapy: Critical for maintaining hydration, especially in cats with oral ulcers that prevent adequate water intake 1
- Nutritional support: Feed highly palatable, blended, or warmed food to anorexic cats. Oral ulcers make eating painful, so food texture and temperature matter 1
- Mucolytic therapy: Bromhexine or nebulization with saline provides relief from respiratory secretions 1
- Broad-spectrum antibiotics: Administer to prevent secondary bacterial infections, which commonly complicate FCV infection 1
Antiviral Considerations
For standard FCV infections, no antiviral therapy is routinely recommended, as supportive care is typically sufficient 1, 2.
For severe or virulent systemic FCV disease (characterized by high fever, cutaneous edema, ulcerative lesions on head/limbs, jaundice, and high mortality):
- Nitazoxanide shows potent inhibition of FCV replication with EC50 of 0.6 μM in vitro 3
- 2'-C-methylcytidine (2CMC) demonstrates antiviral effects with EC50 of 2.5 μM 3
- Virus-specific phosphorodiamidate morpholino oligomers (PMOs): In outbreak settings, PMOs administered at 0.7-5.0 mg/kg SC daily for up to 7 days showed dramatic survival benefit (47/59 cats survived with PMO vs 3/31 without treatment) 4
Important caveat: Most antiviral drugs are either ineffective systemically or toxic in cats, limiting their clinical application 2. The PMO data is compelling but represents experimental treatment during specific outbreaks 4.
Immunoglobulin Therapy
Controlled studies demonstrate that immunoglobulins significantly reduce clinical signs of FCV infection faster than supportive care alone 2. This represents a viable adjunctive therapy option in severe cases.
Environmental Management
FCV persists in the environment for approximately 1 month and resists many common disinfectants 1. Aggressive environmental decontamination is essential, particularly in multicat households or shelters where FCV is most problematic.
Vaccination Status
Cats that have recovered from FCV infection should still be vaccinated, as infection-induced immunity is not lifelong and does not protect against all strains 1, 5. Vaccination protects against disease severity but not infection itself 5.
In fully vaccinated cats that develop disease, consider changing to different vaccine strain(s), given FCV's high genetic variability 5.
Clinical Pitfalls
- PCR interpretation: Positive PCR results require caution, as they may reflect low-level shedding by asymptomatic carriers rather than active disease 1
- Diagnosis of virulent systemic FCV: Relies on clinical signs (fever, cutaneous lesions, jaundice) plus isolation of the same strain from blood of multiple diseased cats 1
- Chronic gingivostomatitis: FCV can be isolated from nearly all cats with chronic stomatitis/gingivitis, but this doesn't necessarily mean FCV is the primary driver—consider multifactorial etiology 1
Prognosis
With appropriate supportive care, mortality is now less than 1% in properly treated patients with standard FCV infection 1. However, virulent systemic FCV disease carries mortality rates up to 50%, with more severe disease in adult cats 1, 3.